Literature DB >> 32336110

AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays.

Jagarlamudi Kiran Kumar1, Sofia Holmgren2,3, Kerstin Hamberg Levedahl3, Martin Höglund3, Per Venge2,3, Staffan Eriksson1,4.   

Abstract

Thymidine kinase 1 (TK1) is an enzyme involved in DNA precursor synthesis that has been used as a biomarker for prognosis and monitoring of different malignancies. In this study, we compared two immunoassays for measuring TK1 protein concentrations: the TK 210 ELISA (AroCell AB) and TK1 ELISA from Abcam. Overall, the TK 210 ELISA showed higher sensitivity than the Abcam TK1 ELISA for differentiating hematological malignancies (sensitivity of 0.77 vs 0.45) as well as for distinguishing sera of patients with solid tumors from those of apparently healthy individuals (0.61 vs 0.20). There was no significant difference in the TK1 protein levels determined with the TK 210 ELISA between different age groups from apparently healthy individuals. These results strongly indicate that the AroCell TK 210 ELISA is accurate and sensitive enough to be a valuable tool in cancer management.

Entities:  

Keywords:  AroCell TK 210 ELISA; anti-human TK1 antibodies; hematological malignancies; serum thymidine kinase 1 (STK1)

Year:  2020        PMID: 32336110     DOI: 10.2144/btn-2019-0148

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  5 in total

1.  Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma.

Authors:  Johan Mattsson Ulfstedt; Per Venge; Sofia Holmgren; Gunilla Enblad; Staffan Eriksson; Daniel Molin
Journal:  Ups J Med Sci       Date:  2021-08-20       Impact factor: 2.384

2.  Differential expression of enzymes in thymidylate biosynthesis in zebrafish at different developmental stages: implications for dtymk mutation-caused neurodegenerative disorders.

Authors:  Junmei Hu Frisk; Stefan Örn; Gunnar Pejler; Staffan Eriksson; Liya Wang
Journal:  BMC Neurosci       Date:  2022-03-27       Impact factor: 3.288

3.  Application Value of Serum TK1 and PCDGF, CYFRA21-1, NSE, and CEA plus Enhanced CT Scan in the Diagnosis of Nonsmall Cell Lung Cancer and Chemotherapy Monitoring.

Authors:  Xiang He; Ming Wang
Journal:  J Oncol       Date:  2022-03-25       Impact factor: 4.375

4.  Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer.

Authors:  Per-Olof Lundgren; Bernhard Tribukait; Anders Kjellman; Ulf Norming; Kiran Jagarlmudi; Ove Gustafsson
Journal:  Prostate       Date:  2022-03-16       Impact factor: 4.012

5.  Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.

Authors:  K K Jagarlamudi; Swinkels L; Zupan M; Osredkar J; Venge P; Eriksson S
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.